Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Two Biphasic Insulin Aspart 30 Initiation Regimens in T2DM
NCT01215435Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2011
- Primary completion
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of biphasic insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2011; status: completed.
02
Drugs
biphasic insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01215435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01215435.